When was 23andMe founded?

23andMe was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is 23andMe located?

23andMe is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California.

Who is the current CEO of 23andMe?

Anne Wojcicki of 23andMe. They have also founded 1 company and are angel investors in 36 startups, including .

How many employees does 23andMe have?

As of May 31, 2026, the latest employee count at 23andMe is 555.

Is 23andMe a funded company?

23andMe is a funded company, having raised a total of $944M across 22 funding rounds to date. The company's 1st funding round was raised for an undisclosed amount in a Series A round on May 22, 2007.

How much is 23andMe worth?

The last known valuation of 23andMe was $305M as of Jun 13, 2025.

When was the latest funding round of 23andMe?

23andMe's latest funding was a $20M Post IPO round on Nov 03, 2023, with participation from 1 investor.

What is the annual revenue of 23andMe?

Annual revenue of 23andMe is $190M as on Mar 31, 2025.

Is 23andMe a Healthcare Booking Platforms company?

The primary sectors of 23andMe are Healthcare Booking Platforms and Genomics.

Where does 23andMe rank among its competitors?

23andMe ranks 2nd amongst 37 active competitors, of which 2 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was 23andMe, which secured $20M in Nov, 2023.

Who are the top competitors of 23andMe?

23andMe's top competitors include Ancestry, Color and Veritas Genetics. Among them, 23andMe secured the most recent funding round in November, 2023.

23andMe - 2026 Company Profile, Team, Funding, Competitors & Financials

23andMe is an acquired company based in Sunnyvale (United States), founded in 2006 by Anne Wojcicki, Linda Avey and Paul Cusenza. It operates as a Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. 23andMe has raised $944M in funding from investors like Fidelity Investments, Sequoia Capital and Google Ventures, with last known valuation of $305M. The company has 37 active competitors, including 2 funded and 8 that have exited. Its top competitors include companies like Ancestry, Color and Veritas Genetics.

Sectors and market segments that 23andMe operate in

23andMe serves in the HealthTech, Life Sciences market segments.The primary business model of 23andMe are:

Company Details

Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. The platform provides a study regarding an individual's ancestry, genealogy, and inherited traits. The company also markets its data is categorized and searchable form to researchers and scientists.

Website: www.23andme.com
Social
Email ID: *****@23andme.com
Phone Number: +1 **********
Registered Address: Sunnyvale, California

Key Metrics

Founded Year

2006

Location

Sunnyvale, United States

Stage

Acquired

Total Funding

$944M in 22 rounds

Latest Funding Round

Post IPO, Nov 03, 2023, $20M

Last Known Valuation

$305M as on Jun 13, 2025

Investors

Fidelity Investments & 33 more

Ranked

2^nd among 37 active competitors

Annual Revenue

$190M as on Mar 31, 2025

Employee Count

555 as on May 31, 2026

Investment & Acquisitions

Halo & 3 more

Similar Companies

Ancestry & 134 more

Exit Details

Acquired by TTAM Research Institute (Jun 13, 2025)

View 23andMe's full profile

23andMe is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
23ANDME, INC. CIN: 204857371 , United States, Active	Dec 31, 2005	-	478 (As on Dec 31, 2024)	-
23ANDME HOLDING CO. CIN: 1804591 , United States, Active	Jun 15, 2021	$190M (As on Mar 31, 2025)	-	-
23andme, Inc. CIN: 20161206900 , United States, Active	Mar 24, 2016	-	-	-

23andMe got acquired by TTAM Research Institute on Jun 13, 2025 at an acquisition amount of $*****.

Click here to take a look at 23andMe's acquisition in detail

23andMe has raised a total funding of $944M over 22 rounds. Its first funding round was on May 22, 2007. Its latest funding round was a Post IPO round on Nov 03, 2023 for $20M. 1 investor participated in its latest round. 23andMe has 31 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of 23andMe:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 03, 2023	$20M	Post IPO	-	-	-	GSK
Dec 09, 2020	$82.5M	Series F	-	-	-	Sequoia Capital, NewView Capital
Jul 24, 2018	$300M	Series F	$1.75B	-	GSK	-

Access funding benchmarks and valuations. Sign up today!

View details of 23andMe's funding rounds and investors

The founders of 23andMe are Anne Wojcicki, Linda Avey and Paul Cusenza. Anne Wojcicki is the CEO of 23andMe.

Here are the details of 23andMe's key team members:

Anne Wojcicki: Co-Founder & CEO of 23andMe. They are also an angel investor in 36 startups.
Contact Info: 1 email address
Linda Avey: Former Co-Founder of 23andMe and founder of 1 other company.
Paul Cusenza: Co-Founder & Co-President; Board Member of 23andMe.

View details of 23andMe's Founder profiles and Board Members

23andMe's employee count trend

23andMe has 555 employees as of May 26. Here is 23andMe's employee count trend over the years:

Uncover 23andMe's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of 23andMe include Ancestry, Color and Veritas Genetics. Here is the list of Top 10 competitors of 23andMe, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ancestry 1996, Lehi (United States), Acquired	Provider of an online genealogy platform offering a host of services	$446M	Meritech, Adams Street Partners & 18 others	82/100
2nd	23andMe 2006, Sunnyvale (United States), Acquired	Provider of genetic test solutions to study ancestry, genealogy, and inherited traits	$944M	SeedFord Partners, Fidelity Investments & 32 others	78/100
3rd	Color 2013, Burlingame (United States), Series E	Provider of end-to-end Virtual clinic offering cancer-based solutions	$491M	General Catalyst, T. Rowe Price & 46 others	66/100
4th	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	58/100
5th	Nebula Genomics 2016, San Francisco (United States), Acquired	Developer of DNA Sequencing technology for personal genomics	$4.3M	Windham Venture Partners, F-Prime Capital ... & 12 others	47/100
6th	Full Genomes 2012, Rockville (United States), Public	Consumer facing genome sequencing company	$602K	-	41/100
7th	My Toolbox Genomics 2020, Walnut (United States), Unfunded	Provider of an app for gene testing	-	-	36/100
8th	GEDmatch 2010, San Diego (United States), Acquired	DNA-based health risk assessment platform	-	-	34/100
9th	Genoplan 2014, New York City (United States), Series B	Developer of genetic test kits for health analysis	$20M	SparkLabs, GC Holdings & 10 others	34/100
10th	Family Tree DNA 2000, Houston (United States), Unfunded	Provider of genetic tests for ancestral history	-	-	30/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on 23andMe's competitors? Click here to see the top ones

23andMe has made 2 investments in companies including Halo and Orchid. 23andMe has also acquired 2 companies including Icebreaker Health and CureTogether.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 21, 2022	Investments	Halo	2016	Chicago (United States)
Oct 22, 2021	Acquisition	Icebreaker Health	2014	San Francisco (United States)
Apr 07, 2021	Investments	Orchid	2019	Armadale (Australia)